CX Institutional boosted its holdings in Cboe Global Markets, Inc. (NASDAQ:CBOE – Free Report) by 15.4% in the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 5,664 shares of the company’s stock after purchasing an additional 757 shares during the period. CX Institutional’s holdings in Cboe Global Markets were worth $1,282,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently bought and sold shares of CBOE. NBC Securities Inc. acquired a new stake in Cboe Global Markets during the first quarter valued at approximately $27,000. Greenline Partners LLC acquired a new stake in Cboe Global Markets during the fourth quarter valued at approximately $29,000. Lee Danner & Bass Inc. acquired a new stake in Cboe Global Markets during the fourth quarter valued at approximately $29,000. Kestra Investment Management LLC acquired a new stake in Cboe Global Markets during the fourth quarter valued at approximately $31,000. Finally, Generali Asset Management SPA SGR acquired a new stake in Cboe Global Markets during the fourth quarter valued at approximately $37,000. Hedge funds and other institutional investors own 82.67% of the company’s stock.
Insider Activity at Cboe Global Markets
In other news, EVP Catherine R. Clay sold 3,598 shares of Cboe Global Markets stock in a transaction on Friday, May 23rd. The stock was sold at an average price of $226.58, for a total transaction of $815,234.84. Following the transaction, the executive vice president now directly owns 2,183 shares in the company, valued at approximately $494,624.14. This trade represents a 62.24% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.22% of the stock is owned by insiders.
Wall Street Analysts Forecast Growth
Read Our Latest Analysis on Cboe Global Markets
Cboe Global Markets Stock Up 1.5%
CBOE opened at $226.30 on Friday. Cboe Global Markets, Inc. has a 12 month low of $166.13 and a 12 month high of $236.02. The company has a debt-to-equity ratio of 0.34, a current ratio of 1.78 and a quick ratio of 1.39. The stock has a market cap of $23.70 billion, a P/E ratio of 31.34, a P/E/G ratio of 1.75 and a beta of 0.43. The stock’s 50 day moving average price is $221.21 and its 200 day moving average price is $211.45.
Cboe Global Markets (NASDAQ:CBOE – Get Free Report) last posted its earnings results on Friday, May 2nd. The company reported $2.50 EPS for the quarter, beating the consensus estimate of $2.36 by $0.14. Cboe Global Markets had a return on equity of 22.02% and a net margin of 18.64%. During the same period in the previous year, the company posted $2.15 EPS. The company’s revenue was up 12.6% compared to the same quarter last year. As a group, research analysts predict that Cboe Global Markets, Inc. will post 8.96 earnings per share for the current year.
Cboe Global Markets Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, June 13th. Investors of record on Friday, May 30th will be given a $0.63 dividend. This represents a $2.52 annualized dividend and a yield of 1.11%. The ex-dividend date is Friday, May 30th. Cboe Global Markets’s dividend payout ratio is currently 33.03%.
About Cboe Global Markets
Cboe Global Markets, Inc is one of the largest stock exchange operators by volume in the United States and a leading market globally for ETP trading. Cboe offers trading across a diverse range of products in multiple asset classes and geographies, including options, futures, U.S. and European equities, exchange-traded products (ETPs), global foreign exchange (FX) and multi-asset volatility products based on the VIX Index.
Featured Stories
- Five stocks we like better than Cboe Global Markets
- Best Aerospace Stocks Investing
- Ignore the Noise—Samsara Stock Is Still a Strong Buy
- How to Evaluate a Stock Before Buying
- 3 Stocks Set to Double—And There’s Still Time to Buy
- ETF Screener: Uses and Step-by-Step Guide
- Analysts Can’t Get Enough of These Little-Known Biopharma Stocks
Receive News & Ratings for Cboe Global Markets Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cboe Global Markets and related companies with MarketBeat.com's FREE daily email newsletter.